Published in
13.01 - Pulmonary hypertension, 2022
DOI: 10.1183/13993003.congress-2022.4371
Elsevier, Pulmonology, 2023
DOI: 10.1016/j.pulmoe.2022.11.004
Links
Tools
Effect of 5 weeks of oral acetazolamide on patients with pulmonary vascular disease: A randomized, double-blind, cross-over trial
Journal article published in 2023 by
M. Lichtblau 
,
S. Saxer ,
J. Müller,
P. Appenzeller,
C. Berlier,
S. R. Schneider ,
Schneider Sr,
L. Mayer,
M. Furian ,
Schwarz Ei,
E. I. Schwarz,
Swenson Er,
E. R. Swenson,
K. E. Bloch,
Bloch Ke
and other authors.
,
S. Saxer ,
J. Müller,
P. Appenzeller,
C. Berlier,
S. R. Schneider ,
Schneider Sr,
L. Mayer,
M. Furian ,
Schwarz Ei,
E. I. Schwarz,
Swenson Er,
E. R. Swenson,
K. E. Bloch,
Bloch Ke
and other authors.
